Neuland Laboratories Limited has informed the Exchange regarding 'Compliance Certificate pursuant to SEBI Exemption Order dated January 3, 2025 for the financial year ended March 31, 2025'.
NEULANDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Davuluri Ownership Trust, an entity associated with Neuland Laboratories' promoter group, has submitted an annual compliance certificate to BSE, NSE, and SEBI for the financial year ended March 31, 2025. The certificate relates to SEBI Exemption Order No. WTM/ASB/CFD/17/2024-25 dated January 3, 2025, granted under Regulation 11 of the SEBI Takeover (SAST) Regulations, 2011. Independent auditor M/s. B Srinivasa Rao & Co. has examined the relevant records and certified that the Trust has complied with all conditions of the exemption order and applicable SEBI SAST provisions. The filing was made on June 10, 2025, and is purely procedural in nature.
This is a routine regulatory compliance submission and is not expected to have any material impact on the stock price or shareholders. It simply confirms that the promoter-linked Trust has met the ongoing conditions attached to a prior SEBI exemption from certain takeover code requirements.